Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
J Surg Oncol
    July 2026
  1. CANTILLON OT, Busam KJ, Ariyan CE, Bartlett EK, et al
    Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non-Clinical Trial Setting.
    J Surg Oncol. 2026 Jul 19. doi: 10.1002/jso.70324.
    >> Share

    April 2026
  2. ADAWI Q, Meiri H, Yoschpe A, Shapira R, et al
    Augmented Reality Based 3D Modelling for Sentinel Lymph Node Localization in Cutaneous Melanoma: A Pilot Study.
    J Surg Oncol. 2026 Apr 29. doi: 10.1002/jso.70282.
    >> Share

  3. DUARTE-BATEMAN D, Shen A, Chen Y, Arpi-Palacios J, et al
    Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients.
    J Surg Oncol. 2026 Apr 19. doi: 10.1002/jso.70252.
    >> Share

    March 2026
  4. GEHLE DB, Morgan PW, Fitts EM, Hauser NL, et al
    Universal Risk Stratification in Stage I-III Cutaneous Melanoma Using 31-gene Expression Profiling: A Single-Center Study.
    J Surg Oncol. 2026 Mar 8. doi: 10.1002/jso.70229.
    >> Share

  5. ZHANG Y, Li C, Shan L
    Comment On "Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node-Positive Melanoma: Feasibility, Safety, and Early Outcomes".
    J Surg Oncol. 2026 Mar 1. doi: 10.1002/jso.70218.
    >> Share

    November 2025
  6. LI RA, Nguyen AT, Bajaj K, Coles BM, et al
    Disparities in Cutaneous Melanoma Diagnosis and Survival Among American Indian and Alaskan Native Patients: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Nov 24. doi: 10.1002/jso.70136.
    >> Share

  7. JONSSON EL, Fraser Hill WK, Saayman M, Yakaback S, et al
    Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node-Positive Melanoma: Feasibility, Safety, and Early Outcomes.
    J Surg Oncol. 2025 Nov 5. doi: 10.1002/jso.70127.
    >> Share

    October 2025
  8. DE LA CRUZ KU G, Ziegler-Rodriguez G, Desai A, Delgado LP, et al
    The Melanoma Divide: Hispanic Health Disparities From Peru to the United States.
    J Surg Oncol. 2025 Oct 14. doi: 10.1002/jso.70110.
    >> Share

  9. LEE KT, Kim S, Mun GH
    Excision Depth and Prognosis in T1-T3 Plantar Melanoma: Is Complete Excision of Plantar Fat Pad Necessary?
    J Surg Oncol. 2025 Oct 13. doi: 10.1002/jso.70108.
    >> Share

    September 2025
  10. HANSEN SM, Jensen MB, Bidstrup PE, Johansen C, et al
    Identification of Sub-Groups of Patients Surgically Treated for Melanoma With Affected Health-Related Quality of Life and Psychosocial Well-Being.
    J Surg Oncol. 2025 Sep 29. doi: 10.1002/jso.70104.
    >> Share

  11. TAQI K, Jonsson EL, Assadzad GE, Stockley C, et al
    Superparamagnetic Iron Oxide Tracer: A Magnetic Match to Gold Standard in Melanoma Sentinel Lymph Node Biopsy-A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Sep 10. doi: 10.1002/jso.70086.
    >> Share

    August 2025
  12. KING A, Brandts-Longtin O, Somayaji C, McDonald JT, et al
    Impact of Social Determinants on Melanoma Outcomes in Canada: A Single-Centre Retrospective Study.
    J Surg Oncol. 2025 Aug 28. doi: 10.1002/jso.70069.
    >> Share

    July 2025
  13. YANG Y, Fang H, Cai Z, Xu Q, et al
    Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Melanoma: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Jul 11. doi: 10.1002/jso.70039.
    >> Share

  14. LAL T, Dong W, Koroukian SM, Chakraborty NN, et al
    Socioeconomic Influences on Melanoma Incidence Patterns by Stage in the US.
    J Surg Oncol. 2025 Jul 10. doi: 10.1002/jso.70036.
    >> Share

  15. WEITEMEYER MB, Helvind NM, Klausen S, Clasen-Linde E, et al
    Validation of a Clinicopathologic and Gene Expression Model for Predicting Sentinel Node Metastasis in Melanoma: A Multicenter Danish Cohort Study.
    J Surg Oncol. 2025 Jul 7. doi: 10.1002/jso.70035.
    >> Share

    February 2025
  16. LIU W, Yang Y
    Comment on "Lymph Node Dissection for Melanoma: Contemporary Trends in Postoperative Outcomes and Patient Selection With Reduced Case Volumes in the Post-MSLT2 Era".
    J Surg Oncol. 2025 Feb 12. doi: 10.1002/jso.28118.
    >> Share

    January 2025
  17. FAROOQ MS, Vargas GM, Shafique N, Guo J, et al
    Lymph Node Dissection for Melanoma: Contemporary Trends in Postoperative Outcomes and Patient Selection With Reduced Case Volumes in the Post-MSLT2 Era.
    J Surg Oncol. 2025 Jan 8. doi: 10.1002/jso.28075.
    >> Share

  18. FANNING JE, Chung DKV, Reynolds HM, Jayathungage Don TD, et al
    Collateralization of the upper extremity lymphatic system after axillary lymph node dissection.
    J Surg Oncol. 2025;131:47-53.
    >> Share

    December 2024
  19. DE LA CRUZ KU G, Guart JA, Farzan JJ, Desai A, et al
    Real World Data in Stage III Melanoma in Latino Low Middle Income Country: Prognostic Factors and Outcomes.
    J Surg Oncol. 2024 Dec 29. doi: 10.1002/jso.28047.
    >> Share

    November 2024
  20. LOURDAULT K, Cowman AW, Hanes D, Scholer AJ, et al
    Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?
    J Surg Oncol. 2024 Nov 17. doi: 10.1002/jso.27976.
    >> Share

    October 2024
  21. YEE EJ, Thielen ON, Truong R, Gilbert D, et al
    Metastatic Melanoma to the Small Bowel and Colon: A Systematic Review of the Global Experience and Institutional Cohort Analysis Detailing a Rare Clinical Entity.
    J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27958.
    >> Share

  22. DRUSKOVICH C, Kelley J, Aubrey J, Palladino L, et al
    A Review of Melanoma Subtypes: Genetic and Treatment Considerations.
    J Surg Oncol. 2024 Oct 16. doi: 10.1002/jso.27953.
    >> Share

  23. DHEER A, Tortorello GN, Shafique N, Farooq MS, et al
    Sequencing of Immunotherapy and Outcomes in Operable Clinical Stage III Melanoma: A National Cohort Study.
    J Surg Oncol. 2024 Oct 3. doi: 10.1002/jso.27933.
    >> Share

    September 2024
  24. LI J, Cheng W
    Letter Regarding "Factors Associated With Skeletal-Related Events in Patients With Bone Metastatic Melanoma: A Retrospective Study of 481 Patients".
    J Surg Oncol. 2024 Sep 30. doi: 10.1002/jso.27915.
    >> Share

    August 2024
  25. FANNING JE, Singhal D, Reynolds HM, Don TDJ, et al
    Patterns of forearm lymphatic drainage to the epitrochlear lymph nodes in 1400 cutaneous melanoma patients.
    J Surg Oncol. 2024 Aug 13. doi: 10.1002/jso.27811.
    >> Share

  26. SANTOS RLD, Martins MR, Tavares VL, Neto JPD, et al
    Analysis of the expression of cytokines and chemokines, platelet-leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma.
    J Surg Oncol. 2024 Aug 11. doi: 10.1002/jso.27748.
    >> Share

    June 2024
  27. SHIMIZU MR, de Groot TM, Twining PK, Kobes T, et al
    Factors associated with skeletal-related events in patients with bone metastatic melanoma: A retrospective study of 481 patients.
    J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27731.
    >> Share

    May 2024
  28. GREENE AC, Matzelle-Zywicki M, Ziegler O, El-Mallah JC, et al
    Characteristics and variations in young adults with cutaneous melanoma: A national cancer database analysis.
    J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27685.
    >> Share

  29. PARKER LM, Beekman KE, DePalo DK, Elleson KM, et al
    Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: Can we predict involvement?
    J Surg Oncol. 2024 May 8. doi: 10.1002/jso.27664.
    >> Share

    March 2024
  30. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    A national database analysis of the evolution of outcomes of surgery for anal melanoma.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631.
    >> Share

  31. STEADMAN JA, Glasgow AE, Neequaye NN, Habermann EB, et al
    Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27608.
    >> Share

  32. KADHUM M, Mayr L, Pope-Jones S, Cubitt J, et al
    Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27617.
    >> Share

    November 2023
  33. MALEKZADEH P, Brady MS
    Adjuvant therapy for stage IIB + IIC melanoma.
    J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27534.
    >> Share

  34. KAKISH H, Lal T, Thuener JE, Bordeaux JS, et al
    Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
    J Surg Oncol. 2023 Nov 29. doi: 10.1002/jso.27543.
    >> Share

  35. GOYAL A, Fei-Zhang DJ, Pawlik TM, Bentrem DJ, et al
    Associations of social vulnerability with truncal and extremity melanomas in the United States.
    J Surg Oncol. 2023 Nov 27. doi: 10.1002/jso.27532.
    >> Share

  36. KAKISH H, Drigotas C, Ahmed FA, Elshami M, et al
    The effect of surgical timing in nonmetastatic melanoma.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27507.
    >> Share

  37. ASAI Y, Yanagawa N, Osakabe M, Yamada N, et al
    The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
    J Surg Oncol. 2023 Nov 2. doi: 10.1002/jso.27487.
    >> Share

    September 2023
  38. LIN X, Sun W, Ren M, Xu Y, et al
    Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
    J Surg Oncol. 2023 Sep 10. doi: 10.1002/jso.27438.
    >> Share

    July 2023
  39. FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al
    Anorectal melanoma.
    J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381.
    >> Share

    April 2023
  40. ASARE EA, Fisher SB, Chiang YJ, Haydu LE, et al
    Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
    J Surg Oncol. 2023 Apr 3. doi: 10.1002/jso.27267.
    >> Share

    March 2023
  41. HOLTKAMP LHJ, Lo SN, Thompson JF, Spillane AJ, et al
    Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection.
    J Surg Oncol. 2023 Mar 27. doi: 10.1002/jso.27245.
    >> Share

  42. SANTAMARIA-BARRIA JA, Matsuba C, Khader A, Scholar AJ, et al
    Age-related next-generation sequencing mutational analysis in 1196 melanomas.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27239.
    >> Share

  43. HOSEIN S, Drebin HM, Kurtansky NR, Olofsson Bagge R, et al
    Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27231.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016